Electroporation and bleomycin in glaucoma-filtering surgery

Taiji Sakamoto, Yuji Oshima, Maki Sakamoto, Yo Ichi Kawano, Tatsuro Ishibashi, Hajime Inomata, Yoshitaka Ohnishi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose. To develop a new treatment in glaucoma-filtering surgery using combined treatment with electroporation and the antiproliferative drug bleomycin. Methods. Pigmented rabbits were treated with both bleomycin (10 μg/ml) and localized electric pulses (EP) using a special probe (5 V/cm, 100 msec, 8 pulses) (n = 10; group A). After EP treatment, bleomycin was washed out with 50 ml balanced salt solution, and then a posterior lip sclerectomy was performed on the same area. We also studied rabbits undergoing a posterior lip sclerectomy with bleomycin treatment alone (n = 10; group B), a posterior lip sclerectomy with EP treatment alone (n = 5; group C) and a posterior lip sclerectomy alone using the same operation (n = 5; group D, negative control). The intraocular pressure (IOP) was measured before and 1, 3, 5, 7, 10, 15, and 20 days after surgery. The formation of blebs, the conjunctiva, and the cornea were periodically examined by slit-lamp biomicrography. Results. In every group, the lOP decreased until day 7, and no significant difference was observed among the four groups. In groups B, C, and D (control), the IOP increased gradually from day 10 and thereafter returned to the preoperative level after 15 days. However, in group A, the IOP remained lower than the preoperative level for 20 days; it was also significantly lower than each of the other three groups (P< 0.01). The survival rate of a filtering bleb was significantly higher in group A than in groups B, C, or D, but the survival rate in group B was not higher than groups C or D. No adverse effects were clinically observed in the ocular tissue, such as the cornea and conjunctiva. Conclusions. The combined treatment with EP and bleomycin was found to decrease IOP more prominently than EP or bleomycin treatment alone in filtering surgery. This treatment thus makes filtering surgery effective by decreasing the dose of the antiproliferative drug and by possibly localizing the drug delivery.

Original languageEnglish
Pages (from-to)2864-2868
Number of pages5
JournalInvestigative Ophthalmology and Visual Science
Volume38
Issue number13
Publication statusPublished - Dec 1 1997

Fingerprint

Filtering Surgery
Electroporation
Bleomycin
Glaucoma
Lip
Intraocular Pressure
Conjunctiva
Blister
Cornea
Pharmaceutical Preparations
Rabbits
Ambulatory Surgical Procedures
indium-bleomycin
Salts

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Sakamoto, T., Oshima, Y., Sakamoto, M., Kawano, Y. I., Ishibashi, T., Inomata, H., & Ohnishi, Y. (1997). Electroporation and bleomycin in glaucoma-filtering surgery. Investigative Ophthalmology and Visual Science, 38(13), 2864-2868.

Electroporation and bleomycin in glaucoma-filtering surgery. / Sakamoto, Taiji; Oshima, Yuji; Sakamoto, Maki; Kawano, Yo Ichi; Ishibashi, Tatsuro; Inomata, Hajime; Ohnishi, Yoshitaka.

In: Investigative Ophthalmology and Visual Science, Vol. 38, No. 13, 01.12.1997, p. 2864-2868.

Research output: Contribution to journalArticle

Sakamoto, T, Oshima, Y, Sakamoto, M, Kawano, YI, Ishibashi, T, Inomata, H & Ohnishi, Y 1997, 'Electroporation and bleomycin in glaucoma-filtering surgery', Investigative Ophthalmology and Visual Science, vol. 38, no. 13, pp. 2864-2868.
Sakamoto T, Oshima Y, Sakamoto M, Kawano YI, Ishibashi T, Inomata H et al. Electroporation and bleomycin in glaucoma-filtering surgery. Investigative Ophthalmology and Visual Science. 1997 Dec 1;38(13):2864-2868.
Sakamoto, Taiji ; Oshima, Yuji ; Sakamoto, Maki ; Kawano, Yo Ichi ; Ishibashi, Tatsuro ; Inomata, Hajime ; Ohnishi, Yoshitaka. / Electroporation and bleomycin in glaucoma-filtering surgery. In: Investigative Ophthalmology and Visual Science. 1997 ; Vol. 38, No. 13. pp. 2864-2868.
@article{f377f60761824647b92626f432aa2f10,
title = "Electroporation and bleomycin in glaucoma-filtering surgery",
abstract = "Purpose. To develop a new treatment in glaucoma-filtering surgery using combined treatment with electroporation and the antiproliferative drug bleomycin. Methods. Pigmented rabbits were treated with both bleomycin (10 μg/ml) and localized electric pulses (EP) using a special probe (5 V/cm, 100 msec, 8 pulses) (n = 10; group A). After EP treatment, bleomycin was washed out with 50 ml balanced salt solution, and then a posterior lip sclerectomy was performed on the same area. We also studied rabbits undergoing a posterior lip sclerectomy with bleomycin treatment alone (n = 10; group B), a posterior lip sclerectomy with EP treatment alone (n = 5; group C) and a posterior lip sclerectomy alone using the same operation (n = 5; group D, negative control). The intraocular pressure (IOP) was measured before and 1, 3, 5, 7, 10, 15, and 20 days after surgery. The formation of blebs, the conjunctiva, and the cornea were periodically examined by slit-lamp biomicrography. Results. In every group, the lOP decreased until day 7, and no significant difference was observed among the four groups. In groups B, C, and D (control), the IOP increased gradually from day 10 and thereafter returned to the preoperative level after 15 days. However, in group A, the IOP remained lower than the preoperative level for 20 days; it was also significantly lower than each of the other three groups (P< 0.01). The survival rate of a filtering bleb was significantly higher in group A than in groups B, C, or D, but the survival rate in group B was not higher than groups C or D. No adverse effects were clinically observed in the ocular tissue, such as the cornea and conjunctiva. Conclusions. The combined treatment with EP and bleomycin was found to decrease IOP more prominently than EP or bleomycin treatment alone in filtering surgery. This treatment thus makes filtering surgery effective by decreasing the dose of the antiproliferative drug and by possibly localizing the drug delivery.",
author = "Taiji Sakamoto and Yuji Oshima and Maki Sakamoto and Kawano, {Yo Ichi} and Tatsuro Ishibashi and Hajime Inomata and Yoshitaka Ohnishi",
year = "1997",
month = "12",
day = "1",
language = "English",
volume = "38",
pages = "2864--2868",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "13",

}

TY - JOUR

T1 - Electroporation and bleomycin in glaucoma-filtering surgery

AU - Sakamoto, Taiji

AU - Oshima, Yuji

AU - Sakamoto, Maki

AU - Kawano, Yo Ichi

AU - Ishibashi, Tatsuro

AU - Inomata, Hajime

AU - Ohnishi, Yoshitaka

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Purpose. To develop a new treatment in glaucoma-filtering surgery using combined treatment with electroporation and the antiproliferative drug bleomycin. Methods. Pigmented rabbits were treated with both bleomycin (10 μg/ml) and localized electric pulses (EP) using a special probe (5 V/cm, 100 msec, 8 pulses) (n = 10; group A). After EP treatment, bleomycin was washed out with 50 ml balanced salt solution, and then a posterior lip sclerectomy was performed on the same area. We also studied rabbits undergoing a posterior lip sclerectomy with bleomycin treatment alone (n = 10; group B), a posterior lip sclerectomy with EP treatment alone (n = 5; group C) and a posterior lip sclerectomy alone using the same operation (n = 5; group D, negative control). The intraocular pressure (IOP) was measured before and 1, 3, 5, 7, 10, 15, and 20 days after surgery. The formation of blebs, the conjunctiva, and the cornea were periodically examined by slit-lamp biomicrography. Results. In every group, the lOP decreased until day 7, and no significant difference was observed among the four groups. In groups B, C, and D (control), the IOP increased gradually from day 10 and thereafter returned to the preoperative level after 15 days. However, in group A, the IOP remained lower than the preoperative level for 20 days; it was also significantly lower than each of the other three groups (P< 0.01). The survival rate of a filtering bleb was significantly higher in group A than in groups B, C, or D, but the survival rate in group B was not higher than groups C or D. No adverse effects were clinically observed in the ocular tissue, such as the cornea and conjunctiva. Conclusions. The combined treatment with EP and bleomycin was found to decrease IOP more prominently than EP or bleomycin treatment alone in filtering surgery. This treatment thus makes filtering surgery effective by decreasing the dose of the antiproliferative drug and by possibly localizing the drug delivery.

AB - Purpose. To develop a new treatment in glaucoma-filtering surgery using combined treatment with electroporation and the antiproliferative drug bleomycin. Methods. Pigmented rabbits were treated with both bleomycin (10 μg/ml) and localized electric pulses (EP) using a special probe (5 V/cm, 100 msec, 8 pulses) (n = 10; group A). After EP treatment, bleomycin was washed out with 50 ml balanced salt solution, and then a posterior lip sclerectomy was performed on the same area. We also studied rabbits undergoing a posterior lip sclerectomy with bleomycin treatment alone (n = 10; group B), a posterior lip sclerectomy with EP treatment alone (n = 5; group C) and a posterior lip sclerectomy alone using the same operation (n = 5; group D, negative control). The intraocular pressure (IOP) was measured before and 1, 3, 5, 7, 10, 15, and 20 days after surgery. The formation of blebs, the conjunctiva, and the cornea were periodically examined by slit-lamp biomicrography. Results. In every group, the lOP decreased until day 7, and no significant difference was observed among the four groups. In groups B, C, and D (control), the IOP increased gradually from day 10 and thereafter returned to the preoperative level after 15 days. However, in group A, the IOP remained lower than the preoperative level for 20 days; it was also significantly lower than each of the other three groups (P< 0.01). The survival rate of a filtering bleb was significantly higher in group A than in groups B, C, or D, but the survival rate in group B was not higher than groups C or D. No adverse effects were clinically observed in the ocular tissue, such as the cornea and conjunctiva. Conclusions. The combined treatment with EP and bleomycin was found to decrease IOP more prominently than EP or bleomycin treatment alone in filtering surgery. This treatment thus makes filtering surgery effective by decreasing the dose of the antiproliferative drug and by possibly localizing the drug delivery.

UR - http://www.scopus.com/inward/record.url?scp=0031471087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031471087&partnerID=8YFLogxK

M3 - Article

C2 - 9418741

AN - SCOPUS:0031471087

VL - 38

SP - 2864

EP - 2868

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 13

ER -